Pharmaceuticals
Biologics

Roivant to unveil mosliciguat Phase 2 PH-ILD data at ERS 2026

Topline results from the PHocus study will be presented at the European Respiratory Society Congress on 8 September, followed by an investor call.
Topline results from the PHocus study will be presented at the European Respiratory Society Congress on 8 September, followed by an investor call.
The Biotech Times Editorial Team  · 
Pharmaceuticals

Teva achieves full investment-grade status after S&P upgrade

S&P's upgrade to BBB- means Teva now holds investment-grade ratings from all three major agencies, capping a multi-month credit rehabilitation.
S&P's upgrade to BBB- means Teva now holds investment-grade ratings from all three major agencies, capping a multi-month credit rehabilitation.
The Biotech Times Editorial Team  · 
Medical Devices
Diagnostics

Lumexa Imaging posts Q2 revenue of $264m as advanced volumes rise

Lumexa Imaging swung to a $2.7m net profit in Q2 2026 as advanced imaging volumes grew 6.8% and the company added its ninth
Lumexa Imaging swung to a $2.7m net profit in Q2 2026 as advanced imaging volumes grew 6.8% and the company added its ninth
The Biotech Times Editorial Team  · 
Diagnostics
Regulatory Science

Envetec appoints Thermo Fisher diagnostics chief to board

Envetec has named Patrick S. Jones, president of Thermo Fisher's Clinical Diagnostics Division, as an independent director to support its US expansion.
Envetec has named Patrick S. Jones, president of Thermo Fisher's Clinical Diagnostics Division, as an independent director to support its US expansion.
The Biotech Times Editorial Team  · 
Medical Devices
Bioprocessing
Regulatory Science

Envetec wins California approval for GENERATIONS medical waste system

California's public health regulator has approved the Irish cleantech firm's non-thermal GENERATIONS system for biohazardous and sharps waste treatment.
California's public health regulator has approved the Irish cleantech firm's non-thermal GENERATIONS system for biohazardous and sharps waste treatment.
The Biotech Times Editorial Team  · 
Biologics
Pharmaceuticals

HCW Biologics wins patent allowance for HCW9302 in alopecia areata

The Florida biotech has secured a USPTO notice of allowance covering HCW9302 as an alopecia areata treatment, as Phase 1 data show early signs of
The Florida biotech has secured a USPTO notice of allowance covering HCW9302 as an alopecia areata treatment, as Phase 1 data show early signs of
The Biotech Times Editorial Team  · 
Medical Devices
Pharmaceuticals
Regulatory Science
Biologics

IBA joins PFAROS consortium to test electron beam PFAS destruction

IBA will co-lead end-of-life and waste-management work in a 91-partner EU initiative targeting PFAS removal from healthcare and pharmaceutical waste
IBA will co-lead end-of-life and waste-management work in a 91-partner EU initiative targeting PFAS removal from healthcare and pharmaceutical waste
The Biotech Times Editorial Team  · 
Pharmaceuticals
Bioinformatics

NorthStrive Biosciences expands AI drug discovery pact with Yuva

NorthStrive Biosciences has formalised a six-month expansion programme to narrow four AI-discovered mitochondrial compounds toward a lead nomination in cardiac disease
NorthStrive Biosciences has formalised a six-month expansion programme to narrow four AI-discovered mitochondrial compounds toward a lead nomination in cardiac disease
The Biotech Times Editorial Team  · 
Medical Devices
Pharmaceuticals
Biologics

Vivos publishes peer-reviewed data on PrecisionGel thermogel

Vivos Inc. has validated its PrecisionGel polymer platform in an Elsevier journal, supporting clinical programmes at Mayo Clinic and licensing talks with pharmaceutical
Vivos Inc. has validated its PrecisionGel polymer platform in an Elsevier journal, supporting clinical programmes at Mayo Clinic and licensing talks with pharmaceutical
The Biotech Times Editorial Team  · 
Medical Devices

Szeged treats 70+ patients in first month of robotic cardiology

Hungary's first robotic cardiology programme treated over 70 arrhythmia patients in its opening month, a record pace for Stereotaxis's Genesis system.
Hungary's first robotic cardiology programme treated over 70 arrhythmia patients in its opening month, a record pace for Stereotaxis's Genesis system.
The Biotech Times Editorial Team  · 
Pharmaceuticals
Genomics

Oryzon wins US patent allowance for iadademstat-gilteritinib AML combo

The USPTO notice covers LSD1 inhibitor combinations for myeloid cancers, with protection expected to run to 2042 pending formal grant.
The USPTO notice covers LSD1 inhibitor combinations for myeloid cancers, with protection expected to run to 2042 pending formal grant.
The Biotech Times Editorial Team  · 
Pharmaceuticals
Biologics

Nxera Pharma to receive $8.6m milestone from Lilly-owned Centessa

A late-stage development advance in Centessa's OX2R agonist pipeline triggers an $8.6 million payment to Nxera, which retains future milestone and royalty
A late-stage development advance in Centessa's OX2R agonist pipeline triggers an $8.6 million payment to Nxera, which retains future milestone and royalty
The Biotech Times Editorial Team  · 
Subscribe to